F1SCHEDULE 1Marketing authorisations
Annotations:
Amendments (Textual)
F1PART 8Pharmacovigilance
Qualified persons responsible for pharmacovigilanceF155
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Duties relating to the qualified personF156
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adverse reactions to a veterinary medicinal product administered in the United KingdomF157
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adverse reactions to a veterinary medicinal product administered in a third countryF158
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Periodic safety update reportsF159
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Release of information by the marketing authorisation holderF160
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Action taken on account of pharmacovigilanceF161
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulations revoked (1.10.2011) by The Veterinary Medicines Regulations 2011 (S.I. 2011/2159), regs. 1, 46(1)